Deep Track Capital, LP 13F 持仓 · 2026年Q2
Deep Track Capital 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 66 只证券，申报市值合计 68.70 亿美元。前几大持仓：GH（7.41%）、IMVT（5.24%）、GPCR（3.70%）。本季前 25 大持仓中：新建仓 2 只、增持 14 只、减持 6 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | GH | GUARDANT HEALTH INC | $509.1M | 7.41% | 3.4M | 增持 |
| 2 | IMVT | IMMUNOVANT INC | $359.9M | 5.24% | 9.3M | 减持 |
| 3 | GPCR | STRUCTURE THERAPEUTICS INC | $254.4M | 3.70% | 4.7M | 增持 |
| 4 | PCVX | VAXCYTE INC | $250.0M | 3.64% | 4.3M | 持平 |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS INC | $248.3M | 3.61% | 825,000 | 新建仓 |
| 6 | MANE | VERADERMICS INC | $245.9M | 3.58% | 2.0M | 增持 |
| 7 | GMAB | GENMAB A/S | $237.6M | 3.46% | 8.7M | 增持 |
| 8 | TARS | TARSUS PHARMACEUTICALS INC | $230.8M | 3.36% | 3.7M | 增持 |
| 9 | NUVL | NUVALENT INC | $220.2M | 3.21% | 1.8M | 增持 |
| 10 | ALKS | ALKERMES PLC | $209.6M | 3.05% | 4.0M | 增持 |
| 11 | OCUL | OCULAR THERAPEUTIX INC | $193.3M | 2.81% | 19.7M | 持平 |
| 12 | BMRN | BIOMARIN PHARMACEUTICAL INC | $189.3M | 2.75% | 3.3M | 增持 |
| 13 | NRIX | NURIX THERAPEUTICS INC | $187.7M | 2.73% | 7.7M | 增持 |
| 14 | ORKA | ORUKA THERAPEUTICS INC | $183.3M | 2.67% | 1.9M | 减持 |
| 15 | ALMS | ALUMIS INC | $178.6M | 2.60% | 6.3M | 减持 |
| 16 | IONS | IONIS PHARMACEUTICALS INC | $174.4M | 2.54% | 2.2M | 增持 |
| 17 | CMPS | COMPASS PATHWAYS PLC | $172.1M | 2.50% | 12.2M | 持平 |
| 18 | VERA | VERA THERAPEUTICS INC | $171.6M | 2.50% | 4.0M | 减持 |
| 19 | AXSM | AXSOME THERAPEUTICS INC. | $171.3M | 2.49% | 700,000 | 减持 |
| 20 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $136.3M | 1.98% | 7.0M | 增持 |
| 21 | COAG | HEMAB THERAPEUTICS HLDGS INC | $132.3M | 1.93% | 3.6M | 新建仓 |
| 22 | TNGX | TANGO THERAPEUTICS INC | $131.3M | 1.91% | 4.2M | 增持 |
| 23 | DFTX | DEFINIUM THERAPEUTICS INC | $129.4M | 1.88% | 2.8M | 减持 |
| 24 | GRAL | GRAIL INC | $125.3M | 1.82% | 1.8M | 增持 |
| 25 | BCAX | BICARA THERAPEUTICS INC | $121.7M | 1.77% | 4.1M | 增持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR